foxo4 dri peptide senolytic human trial inhibitors targeting FOXO4-p53 interactions and inducing senescent cancer cell-specific apoptosis FOXO4-DRI FOXO4/p53 Peptide – Peptagon
FOXO4 DRI FOXO4 p53 Peptide Peptagon FOXO4 DRI: A Breakthrough Peptide Targeting Aging at Its Roots PARTICLE, s. r. o. FOXO4 DRI Vial 10mg Stemcode Peptides FOXO4 DRI 10mg vial Description RCpeptides
Pay in 4 interest-free payments of $6.77 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13



